A large study looked at eighteen different physical and mental health conditions, segmented by age, gender, and deprivation, in people with and without type 2 diabetes. They found many physical and mental conditions are far more common in people with diabetes than in those without. Read more
Researchers from Duke University have demonstrated that a type 2 diabetes treatment combining two drugs is more effective when the drugs are linked by a heat-sensitive tether, instead of simply being administered at the same time. Read more
The DAPA-HF trial provided evidence for improved mortality and morbidity benefits when using the diabetes drug dapagliflozin, in combination with normal standards of care, for patients with heart failure and reduced left ventricular fraction. Read more
Bayshore becomes the sixth pharma company to issue a recall for the popular diabetes drug metformin, after the FDA found high levels of N-nitrosodimethylamine (NDMA), a probably carcinogen, in tested samples. The recall is for one lot each of the 500- and 750-milligram extended-release metformin. Read more
The COVID-19 pandemic has driven many people away from traditional gyms and fitness centers. How are people coping with the transition to working out at home, and is the new home workout here to stay? Diabetes exercise expert Dr. Sheri Colberg shares her thoughts. Read more
California researchers have developed a “digital biomarker” that they say can use a smartphone’s built-in camera to detect type 2 diabetes. This could potentially an inexpensive and easy to use alternative to blood draws, and could be done at home. Read more
A Chinese study found that high glucose levels were a predictor of increased risk for serious complications of COVID-19, including in-hospital death, in people with diabetes. Read more
The makers of LifeScan’s OneTouch Reveal® Plus app have released study findings showing people with type 2 diabetes who used the digital coaching app saw improved health outcomes, with clinically significant reductions in A1C lab values and average blood glucose levels after three and six months. Read more
Long-term chronic wounds reduce quality of life and can increase risk for death in diabetes patients. A recent trial found that there was a significant reduction in the size of diabetic foot ulcers (73.1%) with Single Use Negative Pressure Wound Therapy System (sNPWT). Read more
Researchers say that the class of diabetes drugs called DPP-4 inhibitors, which includes include sitagliptin, saxagliptin, linagliptin, and alogliptin, may be linked to a rare skin condition called bullous pemphigoid, which causes large, fluid-filled blisters due to an abnormal immune system response. Read more
Prediabetes is a condition defined by factors like fasting glucose rate and HbA1c levels that are higher than normal, but below the current definition for diabetes. Now, researchers are finding that many complications associated with diabetes, cardiovascular disease and the risk of death, already begin to rise with prediabetes. Read more
Researchers say they have found evidence that having diabetes may increase the risk of developing Parkinson’s. Diabetes can contribute to the loss of brain cells in Parkinson’s by activating oxidative stress, which is caused by buildup of toxic byproducts of cellular reactions, known as free radicals. Read more
The EarlyBird study investigated the genetic risk markers of type 2 diabetes in healthy children, following 300 children from the ages of 5 to 16 years old to determine who would become at-risk for developing type 2 diabetes, and why. Read more
Diabetes and gout are among the most common metabolic disorders in industrialized nations. While heart disease, kidney disease, and amputations are well known complications of diabetes, researchers are finding that gout also plays a significant role in these problems. Read more
Research has shown that diabetes drugs in the SGLT2 inhibitor class can have cardiovascular benefits. Now the FDA has given a Fast Track Designation to accelerate study of how one of these drugs, Farxiga (dapagliflozin) may help reduce death and heart failure after a heart attack. Read more
People with diabetes are at higher risk for complications of COVID-19, and good diabetes management is key for maximizing health and reducing risk. But for many with type 1, obtaining insulin is a challenge due to job and health insurance losses in the pandemic. Read more
As people age, obesity and diabetes put them at higher risk for cognitive conditions like Alzheimer’s Disease. Type 2 diabetes damages the brain regions that govern memory, movement, and visual processing, but maintaining good glucose levels can help reduce the risk. Read more
Researchers from the Harvard T.H. Chan School of Public Health said that eating one to two portions of brown rice, bulgur, millet or buckwheat reduced people’s risk of type 2 diabetes by 29 per cent compared to those who ate few whole grains. The researchers also found that eating at least one serving of oatmeal […]
For pregnant women with type 1 diabetes, their maternal glucose levels play a large role in determining fetal growth. Continuous glucose monitoring (CGM) allows expecting mothers to assess the changes in their blood glucose levels. Read more
Canadian researchers say they have achieved a scientific breakthrough that could improve the treatment of type 2 diabetes and obesity. They have discovered how to activate brown fat (a tissue responsible for burning calories in excess sugar and fat in the body) in humans. Read more